ACE2 and prognosis of COVID-19: Insights from Bartter's and Gitelman's syndromes patients
- PMID: 32374416
- PMCID: PMC7267417
- DOI: 10.1002/jmv.25978
ACE2 and prognosis of COVID-19: Insights from Bartter's and Gitelman's syndromes patients
Keywords: ACE2; Bartter's syndrome; COVID-19; Gitelman's syndrome.
Comment on
-
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.J Med Virol. 2020 Jul;92(7):726-730. doi: 10.1002/jmv.25785. Epub 2020 Apr 5. J Med Virol. 2020. PMID: 32221983 Free PMC article. Review.
References
-
- Ferrario CM. Angiotensin‐converting enzyme 2 and angiotensin‐(1–7): an evolving story in cardiovascular regulation. Hypertension. 2006;47:515‐521. - PubMed
-
- Sampaio WO, Henrique De Castro C, Santos RAS, Schiffrin EL, Touyz RM. Angiotensin‐(1–7) counterregulates angiotensin II in human endothelial cells. Hypertension. 2007;50:1093‐1098. - PubMed
-
- Ingelfinger JR. Angiotensin‐converting enzyme 2: implications for blood pressure and kidney disease. Curr Opin Nephrol Hypertens. 2009;18:79‐84. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
